share_log

UBS Initiates Coverage On Pediatrix Medical Group With Neutral Rating, Announces Price Target of $9.5

UBS Initiates Coverage On Pediatrix Medical Group With Neutral Rating, Announces Price Target of $9.5

瑞銀以中性評級啓動對Pediatrix醫療集團的保險,宣佈目標股價爲9.5美元
Benzinga ·  2023/11/30 08:43

UBS analyst A.J. Rice initiates coverage on Pediatrix Medical Group (NYSE:MD) with a Neutral rating and announces Price Target of $9.5.

瑞銀分析師A.J. Rice以中性評級開始對Pediatrix Medical Group(紐約證券交易所代碼:MD)進行報道,並宣佈目標股價爲9.5美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論